Tel Aviv, Israel / Vancouver, Canada, April 27, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind” or “the company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced it has formed a Data and Safety Monitoring Board (DSMB) to oversee the…


Previous articlePT407 – The Planet, Psychedelics, and Psyche: Optimism in Ecology
Next articleThe Psychedelic Mind: How Neuroscience Can Help You Navigate Your Inner Landscape